Antiplatelet therapy for secondary prevention of lacunar stroke: a systematic review and network meta-analysis
ConclusionsThis meta-analysis suggests that cilostazol may be a priority option for secondary prevention of patients with LS. These findings still need further study in the future.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Aspirin | Cardiology | Cardiovascular | Cilostazol | Clopidogrel | Databases & Libraries | Drugs & Pharmacology | Heart | Plavix | Science | Stroke | Study